23 results
8-K
EX-99.1
tp6ltr sa9
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
EX-99.1
dorzudkhx41xyv
9 Jun 21
Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors
4:17pm
10-K
xy26tg
12 Mar 20
Annual report
4:16pm
424B4
232hbi hs7o
9 Jan 20
Prospectus supplement with pricing info
5:11pm
DRS
5uf12ra1ch
27 Dec 19
Draft registration statement
12:00am
424B4
if0vzdn8i1go5y8cxp
18 Jul 19
Prospectus supplement with pricing info
4:04pm
S-1
ayb67dx voju2u75r2q
21 Jun 19
IPO registration
3:24pm